πŸ—‚οΈ Navigation

Exscientia

AI-driven drug discovery and development.

Visit Website β†’

Overview

Exscientia is a clinical-stage pharmatech company that has developed a proprietary AI platform to automate and accelerate the drug design and discovery process. Their platform uses AI to generate novel drug candidates with desired properties, significantly reducing the time and cost of preclinical drug discovery. They have a pipeline of co-developed and in-house drug candidates.

✨ Key Features

  • CentaurAIβ„’ platform
  • Generative AI for molecule design
  • Automated drug design
  • Precision medicine
  • End-to-end drug discovery

🎯 Key Differentiators

  • Focus on generative AI for automated drug design.
  • Proven track record of rapidly advancing AI-designed drugs to the clinic.
  • Patient-first approach to AI-driven precision medicine.

Unique Value: Dramatically accelerates the drug discovery process by automating the design of novel drug candidates using AI.

🎯 Use Cases (4)

De novo drug design Lead optimization Target identification Biomarker discovery

βœ… Best For

  • Has brought multiple AI-designed drug candidates to clinical trials, including the first-ever AI-designed molecule for immuno-oncology.

πŸ’‘ Check With Vendor

Verify these considerations match your specific requirements:

  • NA

πŸ† Alternatives

Insilico Medicine Atomwise SchrΓΆdinger

Offers a more automated and generative approach to molecule design compared to platforms focused primarily on screening existing compound libraries.

πŸ’» Platforms

Web API

πŸ”Œ Integrations

API

πŸ›Ÿ Support Options

  • βœ“ Email Support
  • βœ“ Dedicated Support (Enterprise tier)

πŸ’° Pricing

Contact for pricing

Free tier: NA

Visit Exscientia Website β†’